Skip to main content
Caplight Logo









Mevo

Mevo

Private
São PauloHealthcare & Life Scienceshttps://mevo.com.br/

Last Round

Series B

Extension

Mar 25, 2026

Total Funding Raised

$56.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mevo is a healthcare technology company that provides a digital prescription platform and an online pharmacy marketplace to simplify medication access and management for patients, providers, and pharmacies in Brazil.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Marketplace Commission, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

digital prescriptione-prescribingelectronic prescriptionpharmacy integrationhealth-techAPImedication fulfillmenthealthcare infrastructuredigital healthe-healthmedication adherencetelemedicine infrastructurepharmacy marketplaceEMR integrationhealth-tech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mevo Comparables

Compare Mevo with similar companies based on industry and business-model similarity.

Mevo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Memed
93%
Olá Doutor
79%
DrFirst
68%

Mevo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMar 25, 2026
Series B ExtensionNov 28, 2024
Series BSep 18, 2024
Convertible DebtDec 1, 2023
Series AJul 14, 2022
Series A
Jul 8, 2021

Mevo Investors

Notable investors and investment history

Mevo investors
InvestorRounds
MatrixSeries B Extension, Series B
ProsusSeries B Extension
Floating PointSeries B Extension, Series A
Floating Point AdvisorsSeries A, Series B, Series B Extension, Convertible Debt
Arpex CapitalSeries A, Seed
Grupo Santa CruzSeries A
LTS InvestmentsSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 93% MoM, reaching 3.3 million.

  • Mar 30, 2026

    Acquired competitor Receita Digital for an undisclosed amount.

Mevo Filings

Explore SEC and related filing metadata, where available.

Mevo filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mevo's valuation, stock price, and market status.

Is Mevo a public or private company?

Mevo is a private company.

What is the current stock price of Mevo?

Mevo is a private company with no public stock price. No recent secondary market data is available.

How much is Mevo worth (valuation)?

Valuation information for Mevo is not publicly available.

Can I buy Mevo stock?

Mevo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mevo's last funding round?

Mevo's most recent funding round was Series B on March 30, 2026.

Who are the main investors in Mevo?

Key investors in Mevo include Matrix, Prosus, Floating Point Capital.

Will Mevo IPO soon?

No public IPO plans have been announced for Mevo.

How can I track Mevo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mevo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSão Paulo
Employee Range2
Year Founded2017
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?